Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

An expanding panel of monoclonal antibodies (mAbs) that specifically target malignant cells or intercept trophic factors delivered by the tumor stroma is now available for cancer therapy. These mAbs can exert direct antiproliferative/cytotoxic effects as they inhibit pro-survival signal transduction...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Vacchelli, Erika, Pol, Jonathan, Bloy, Norma, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Galon, Jérôme, Marabelle, Aurélien, Kohrt, Holbrook, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4368132/
https://ncbi.nlm.nih.gov/pubmed/25949870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.985940
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados